{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:36:48Z","timestamp":1775911008193,"version":"3.50.1"},"reference-count":37,"publisher":"Institute of Electrical and Electronics Engineers (IEEE)","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/ieeexplore.ieee.org\/Xplorehelp\/downloads\/license-information\/IEEE.html"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IEEE Trans. Comput. Biol. Bioinform."],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1109\/tcbbio.2024.3521790","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T19:18:16Z","timestamp":1735931896000},"page":"503-513","source":"Crossref","is-referenced-by-count":3,"title":["Ligand-Based Pharmacophore Modeling and Quantum Computational Approaches for the Development of hCA XII Inhibitor"],"prefix":"10.1109","volume":"22","author":[{"given":"Venkatesan","family":"Saravanan","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankalathur, Chengalpattu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharath Kumar","family":"Chagaleti","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankalathur, Chengalpattu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakthi Devi","family":"Packiapalavesam","sequence":"additional","affiliation":[{"name":"Dr APJ Abdul Kalam Lab, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankalathur, Chengalpattu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8357-2730","authenticated-orcid":false,"given":"Muthukumaradoss","family":"Kathiravan","sequence":"additional","affiliation":[{"name":"Dr APJ Abdul Kalam Lab, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankalathur, Chengalpattu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"263","reference":[{"key":"ref1","journal-title":""},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1730-1"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211034366"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-823974-2.00014-0"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1042\/bcj20160115"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1021\/bi050610h"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2015.1122001"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/cmdc.200700274","article-title":"Carbonic anhydrase inhibitors: Binding of indanesulfonamides to the human isoform II","volume":"3","author":"D\u2019Ambrosio","year":"2008","journal-title":"Chem. Med. Chem."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1016\/j.bmcl.2010.04.114","article-title":"Carbonic anhydrase inhibitors: Crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms IXV","volume":"20","author":"Di Fiore","year":"2010","journal-title":"Bioorg Med. Chem. Lett."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18311\/jnr\/2024\/36071"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/med.20112"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2467"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1080\/14756366.2020.1825409","article-title":"An overview of carbohydrate-based carbonic anhydrase inhibitors","volume":"35","author":"Cuffaro","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2174\/092986710790979999","article-title":"Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII","volume":"17","author":"Guler","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051045","article-title":"Cancer drug development of carbonic anhydrase inhibitors beyond the active site","volume":"23","author":"Singh","year":"2018","journal-title":"Molecules"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.bmc.2012.09.062","article-title":"Carbonic anhydrase IX as a target for metastatic disease","volume":"21","author":"Gieling","year":"2013","journal-title":"Bioorg Med. Chem."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112923"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-021-01039-8"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01389"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113283"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-981-16-5993-5_9","article-title":"Artificial intelligence and its application in cardiovascular disease management","volume-title":"Machine Learning and Systems Biology in Genomics and Health","author":"Namasivayam","year":"2022"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14383"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"38079","DOI":"10.1039\/D1RA07377J","article-title":"Docking studies and molecular dynamics simulation of triazole benzene sulfonamide derivatives with human carbonic anhydrase IX inhibition activity","volume":"11","author":"Gopinath","year":"2021","journal-title":"RSC Adv."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/cem.2574","article-title":"3D CoMFA, CoMSIA, topomer CoMFA and HQSAR studies on aromatic acid esters for carbonic anhydrase inhibitory activity","volume":"28","author":"Nilewar","year":"2014","journal-title":"J. Chemom."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1039\/D3RA05672D"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/cem.3189"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2017.1367775"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejmech.2018.06.021","article-title":"Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors","volume":"155","author":"Kumar","journal-title":"Eur. J. Med. Chem."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2174\/156802608786786624"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139116","article-title":"Multitargeted molecular docking and dynamics simulation of thymol-based chalcones against cancer protein markers: Synthesis, characterization, and computational study","volume":"1317","author":"Laamari","year":"2024","journal-title":"J. Mol. Struct."},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040788","article-title":"Dual anti-inflammatory and anticancer activity of novel 1,5-diaryl pyrazole derivatives: Molecular modeling, synthesis, in vitro activity, and dynamics study","volume":"12","author":"Deivasigamani","year":"2024","journal-title":"Biomedicines"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1039\/D3RA08618F","article-title":"Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX","volume":"14","author":"Saravanan","year":"2024","journal-title":"RSC Adv."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cplett.2018.02.019"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108073","article-title":"Identification of novel CA IX inhibitor: Pharmacophore modeling, docking, DFT, and dynamic simulation","volume":"110","author":"Packiapalavesam","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1016\/j.comptc.2021.113334","article-title":"In silico drug designing for the identification of promising antagonist hit molecules against Bradykinin receptor","volume":"1202","author":"Selvaraj","year":"2021","journal-title":"Comput. Theor. Chem."}],"container-title":["IEEE Transactions on Computational Biology and Bioinformatics"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx8\/10723156\/10953288\/10819969.pdf?arnumber=10819969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T04:42:40Z","timestamp":1744087360000},"score":1,"resource":{"primary":{"URL":"https:\/\/ieeexplore.ieee.org\/document\/10819969\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":37,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1109\/tcbbio.2024.3521790","relation":{},"ISSN":["2998-4165"],"issn-type":[{"value":"2998-4165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}